Ronald B. Natale, MD, discusses the evolution of immunotherapy in advanced non–small cell lung cancer.
Ronald B. Natale, MD
Advertisement
Articles by Ronald B. Natale, MD
Advertisement
Latest Updated Articles
Dr. Natale on the Evolution of Immunotherapy in NSCLCPublished: May 15th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
4
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
5